Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antisoma updates progress of two anticancer drug candidates

March 23, 2004

New phase II study investigates Tarceva in poor performance NSCLC patients

March 23, 2004

Chiron discontinues development of tezacitabine

March 23, 2004

Pharmacia describes new protein kinase inhibitors, their preparation and use

March 22, 2004

GTx enters collaboration and license agreement with Ortho Biotech for andarine

March 22, 2004

Greater prevention of breast cancer recurrence with exemestane

March 22, 2004

Recombinant immunotoxins against breast cancer, osteosarcoma and neuroblastoma

March 22, 2004

Corgenix Medical and Genesis Bioventures sign merger agreement

March 19, 2004

Maxim reacquires rights to MX-2105 series

March 19, 2004

Novel antiangiogenic tyrosine kinase inhibitor claimed by Boehringer Ingelheim

March 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...